SSC
TDOC icon

Syverson Strege & Co’s Teladoc Health TDOC Stock Holding History

Syverson Strege & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-40
Closed -$4K – 334
2021
Q4 		$4K Hold
40
– – ﹤0.01% 248
2021
Q3 		$5K Hold
40
– – ﹤0.01% 332
2021
Q2 		$7K Buy
+40
New +$6.48K 0.01% 216

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Syverson Strege & Co's TDOC Position: Q1 2022 in Review

Syverson Strege & Co sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 40 shares — an estimated $4K sold.

Syverson Strege & Co first reported a position in TDOC in Q2 2021 and held it in 3 quarters. The position peaked at $7K in Q2 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Syverson Strege & Co reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Syverson Strege & Co sold 40 Teladoc Health shares in Q1 2022, an estimated $4K.
  • Syverson Strege & Co first reported a position in Teladoc Health in Q2 2021 and held it in 3 quarters.
  • Syverson Strege & Co's Teladoc Health position peaked at $7K in Q2 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Syverson Strege & Co's 13F filing for Q1 2022, filed 13 Apr 2022.